The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Open accessAbstract
Inhibition of pancreatic glucagon secretion during hyperglycemia could be mediated by (a) glucose, (b) insulin, (c) somatostatin, or (d) glucose in conjunction with insulin. To determine the role of these factors in the mediation of glucagon suppression, we injected alloxan while clamping the arterial supply of the pancreatic splenic lobe of dogs, thus inducing insulin deficiency localized to the ventral lobe and avoiding hyperglycemia. Ventral lobe insulin, glucagon, and somatostatin outputs were then measured in response to a stepped IV glucose infusion. In control dogs glucagon suppression occurred at a glucose level of 150 mg/dl and somatostatin output increased at glucose greater than 250 mg/dl. In alloxan-treated dogs glucagon output was not suppressed nor did somatostatin output increase. We concluded that insulin was required in the mediation of glucagon suppression and somatostatin stimulation. Subsequently, we infused insulin at high rates directly into the artery that supplied the beta cell-deficient lobe in six alloxan-treated dogs. Insulin infusion alone did not cause suppression of glucagon or stimulation of somatostatin; however, insulin repletion during glucose infusions did restore the ability of hyperglycemia to suppress glucagon and stimulate somatostatin. We conclude that intra-islet insulin permits glucose to suppress glucagon secretion and stimulate somatostatin during hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These opponents interact not only with each other through the intra-islet insulin axis378, 379, 380, 381 but also with other organs/tissues, that is, the brain, liver, gut as well as insulin-dependent adipose and muscle tissues.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [379]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
DRUGS PRODUCING DIABETES THROUGH DAMAGE OF THE INSULIN SECRETING CELLS
Rerup, C. (1970) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06885-1 · Cited by 731
New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat
Bonner‐Weir, S., & Orci, L. (1982) · Diabetes · doi:10.2337/diab.31.10.883 · Cited by 482
Unger, R. H., & Grundy, S. M. (1985) · Diabetologia · doi:10.1007/bf00273856 · Cited by 452
Glucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Interplay of Nutrients and Hormones in the Regulation of Insulin Release*
PIPELEERS, D. G., Schuit, F. C., Veld, P. I. '., Maes, E., Hooghe-Peters, E. L., Winkel, M. V. D., & Gepts, W. (1985) · Endocrinology · doi:10.1210/endo-117-3-824 · Cited by 357
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
Rossetti, L., Shulman, G. I., Zawalich, W. S., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113157 · Cited by 330
Kaestner, K. H., Christy, R. J., McLenithan, J. C., Braiterman, L. T., Cornelius, P. K., Pekala, P. H., & Lane, M. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3150 · Cited by 305
Insulin within islets is a physiologic glucagon release inhibitor
Maruyama, H., Hisatomi, A., Orci, L., Grodsky, G. M., & Unger, R. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111658 · Cited by 303
Alloxan: history and mechanism of action
Lenzen, S., & Panten, U. (1988) · Diabetologia · doi:10.1007/bf02341500 · Cited by 250
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S., & Choi, C. S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,248
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 596
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Islet β-cell secretion determines glucagon release from neighbouring α-cells
Ishihara, H., Maechler, P., Gjinovci, A., Herrera, P. L., & Wollheim, C. B. (2003) · Nature Cell Biology · doi:10.1038/ncb951 · Cited by 391
Skowera, A., Ellis, R. J., Varela‐Calviño, R., Arif, S., Huang, G. C., Van-Krinks, C., Zaremba, A., Rackham, C. L., Allen, J. S., Tree, T. I. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35449 · Cited by 361
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Kawamori, D., Kurpad, A. J., Hu, J., Liew, C. W., Shih, J. L., Ford, E. L., Herrera, P. L., Polonsky, K. S., McGuinness, O. P., & Kulkarni, R. N. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.007 · Cited by 316
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system
Xu, E., Kumar, M., Zhang, Y., Ju, W., Obata, T., Zhang, N., Liu, S., Wendt, A., Deng, S., Ebina, Y., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.015 · Cited by 283
Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Åhrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 276
Wendt, A., Birnir, B., Buschard, K., Gromada, J., Salehi, A. A., Sewing, S., Rorsman, P., & Braun, M. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1038 · Cited by 261
The role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238
Heimberg, H., De Vos, A., Pipeleers, D., Thorens, B., & Schuit, F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8971 · Cited by 188
Åhrén, B., Schweizer, A., Dejager, S., Dunning, B. E., Nilsson, P. M., Persson, M., & Foley, J. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2152 · Cited by 181
Foxa2 regulates multiple pathways of insulin secretion
Lantz, K. A., Vatamaniuk, M. Z., Brestelli, J. E., Friedman, J. R., Matschinsky, F. M., & Kaestner, K. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21149 · Cited by 171
Olsen, H. L., Theander, S., Bokvist, K., Buschard, K., Wollheim, C. B., & Gromada, J. (2005) · Endocrinology · doi:10.1210/en.2005-0800 · Cited by 156
Insulin as a physiological modulator of glucagon secretion
Bansal, P., & Wang, Q. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90295.2008 · Cited by 152
The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells.
Heimberg, H., De Vos, A., Moens, K., Quartier, E., Bouwens, L., Pipeleers, D., Van Schaftingen, E., Madsen, O., & Schuit, F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7036 · Cited by 142
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 144
Dong, H., Kumar, M., Zhang, Y., Gyulkhandanyan, A. V., Xiang, Y.-Y., Ye, B., Perrella, J., Hyder, A., Zhang, N., Wheeler, M. B., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0123-1 · Cited by 118
Glucagon and its Family Revisited
Lefèbvre, P. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.715 · Cited by 112
Taborsky, G. J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400607 · Cited by 96
Self-citationThe Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes
Gilon, P. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.004 · Cited by 93
Webb, G. C., Akbar, M. S., Zhao, C., Swift, H. H., & Steiner, D. F. (2002) · Diabetes · doi:10.2337/diabetes.51.2.398 · Cited by 88
Zhang, Q., Davenport, J. R., Croyle, M. J., Haycraft, C. J., & Yoder, B. K. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700207 · Cited by 92
Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells
Diao, J., Shyr, Z. A., Chan, C. B., & Wheeler, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506276200 · Cited by 87
Chromium propionate enhances insulin sensitivity in growing cattle
Spears, J. W., Whisnant, C. S., Huntington, G. B., Lloyd, K. E., Fry, R. S., Krafka, K., Lamptey, A., & Hyda, J. (2012) · Journal of Dairy Science · doi:10.3168/jds.2011-4845 · Cited by 85
Moffett, R. C., Vasu, S., Thorens, B., Drucker, D. J., & Flatt, P. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096863 · Cited by 75
Melatonin stimulates glucagon secretion in vitro and in vivo
Bähr, I., Mühlbauer, E., Schucht, H., & Peschke, E. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00848.x · Cited by 74
Pedersen, M. G., Ahlstedt, I., El Hachmane, M. F., & Göpel, S. O. (2016) · Scientific Reports · doi:10.1038/srep31214 · Cited by 64
Jun, L. S., Millican, R. L., Hawkins, E. D., Konkol, D. L., Showalter, A. D., Christe, M. E., Michael, M. D., & Sloop, K. W. (2015) · Diabetes · doi:10.2337/db14-1052 · Cited by 60
Evaluation of mulberry leaves’ hypoglycemic properties and hypoglycemic mechanisms
Chen, S., Xi, M., Gao, F., Li, M., Dong, T., Geng, Z., Liu, C., Huang, F., Wang, J., Li, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1045309 · Cited by 61
Suppression of Ca2+ oscillations in glucagon-producing α2-cells by insulin/glucose and amino acids
Berts, A., Ball, A., Gylfe, E., & Hellman, B. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(95)00173-5 · Cited by 50
Salehi, M., Woods, S. C., & D’Alessio, D. A. (2015) · Obesity · doi:10.1002/oby.21186 · Cited by 47
Peptides in the regulation of glucagon secretion
Andersen, D. B., & Holst, J. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170683 · Cited by 50
Fasting Hyperglycemia Impairs Glucose- But Not Insulin-Mediated Suppression of Glucagon Secretion
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1515 · Cited by 46
Cerf, M. E., Chapman, C. S., Muller, C. J. F., & Louw, J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.007 · Cited by 45
Bollheimer, L. C., Landauer, H. C., Troll, S., Schweimer, J., Wrede, C. E., Schölmerich, J., & Buettner, R. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.011 · Cited by 43
Xu, S. F. S., Andersen, D. B., Izarzugaza, J. M. G., Kuhre, R. E., & Holst, J. J. (2020) · Acta Physiologica · doi:10.1111/apha.13464 · Cited by 44
The Role of Glucagon in the Pathophysiology and Management of Diabetes
Kulina, G., & Rayfield, E. J. (2016) · Endocrine Practice · doi:10.4158/ep15984.ra · Cited by 45
Toots, M., Seppa, K., Jagomäe, T., Koppel, T., Pallase, M., Heinla, I., Terasmaa, A., Plaas, M., & Vasar, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-28314-z · Cited by 41
Giacca, A., Fisher, S. J., McCall, R. H., Shi, Z. Q., & Vranić, M. (1997) · Endocrinology · doi:10.1210/endo.138.3.5025 · Cited by 40
Leptin Deficiency in Rats Results in Hyperinsulinemia and Impaired Glucose Homeostasis
D'souza, A. M., Asadi, A., Johnson, J. D., Covey, S. D., & Kieffer, T. J. (2014) · Endocrinology · doi:10.1210/en.2013-1523 · Cited by 36
Mundinger, T. O., Mei, Q., Figlewicz, D. P., Lernmark, Å., & Taborsky, G. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00136.2003 · Cited by 36
Self-citationDumonteil, E., Magnan, C., Ritz-Laser, B., Meda, P., Dussoix, P., Gilbert, M., Ktorza, A., & Philippé, J. (1998) · Endocrinology · doi:10.1210/endo.139.11.6294 · Cited by 33
Ito, K., Maruyama, H., Hirose, H., Kido, K., Koyama, K., Kataoka, K., & Saruta, T. (1995) · Metabolism · doi:10.1016/0026-0495(95)90166-3 · Cited by 31
Pancreatic Islet Responses to Metabolic Trauma
Burke, S. J., Karlstad, M. D., & Collier, J. J. (2016) · Shock · doi:10.1097/shk.0000000000000607 · Cited by 28
Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
Wang, Q., Liang, X., & Wang, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00485 · Cited by 27
Molecular Pathways Underlying the Pathogenesis of Pancreatic α-Cell Dysfunction
Kawamori, D., Welters, H. J., & Kulkarni, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_18 · Cited by 26
Growth factor signalling in the regulation of α ‐cell fate
Kawamori, D., Akiyama, M., Hu, J., Hambro, B., & Kulkarni, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01442.x · Cited by 26
Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
Sekar, R., Singh, K., Arokiaraj, A. W. R., & Chow, B. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.002 · Cited by 26
Strowski, M. Z., Cashen, D. E., Birzin, E. T., Yang, L., Singh, V., Jacks, T. M., Nowak, K. W., Rohrer, S. P., Patchett, A. A., Smith, R. G., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0274 · Cited by 24
Zhang, Y., Zhang, N., Gyulkhandanyan, A. V., Xu, E., Gaisano, H. Y., Wheeler, M. B., & Wang, Q. (2008) · Diabetologia · doi:10.1007/s00125-008-1166-x · Cited by 22
Exploring the molecular mechanisms underlying α- and β-cell dysfunction in diabetes
Kawamori, D. (2017) · Diabetology International · doi:10.1007/s13340-017-0327-x · Cited by 22
Pelegrı́, C., Rosmalen, J. G. M., Durant, S., Throsby, M., Alvès, V., Coulaud, J., Esling, A., Pléau, J., Drexhage, H. A., & Homo‐Delarche, F. (2001) · Molecular Medicine · doi:10.1007/bf03402214 · Cited by 22
Andersen, M. L. M., Rasmussen, M. A., Pörksen, S., Svensson, J., Vikre-Jørgensen, J., Thomsen, J. F., Hertel, N. T., Johannesen, J., Pociot, F., Petersen, J. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064632 · Cited by 21
Kahn, S. E., Mather, K. J., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0460 · Cited by 21
Physiology of the Hypothalamic–Pituitary–Adrenocortical Axis
Vedder, H. (2007) · Neuroimmune biology · doi:10.1016/s1567-7443(07)00202-5 · Cited by 24
Bollheimer, L. C., Wrede, C. E., Rockmann, F., Ottinger, I., Schölmerich, J., & Buettner, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.168 · Cited by 19
Rastogi, K. S., Cooper, R. L., Shi, Z. Q., & Vranić, M. (1997) · Endocrine · doi:10.1007/bf02801332 · Cited by 19
The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review
Guo, K., Tian, Q., Yang, L., & Zhou, Z. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s343514 · Cited by 19
The α-Cell Conundrum: ATP-Sensitive K+ Channels and Glucose Sensing
Jacobson, D. A., Wicksteed, B. L., & Philipson, L. H. (2009) · Diabetes · doi:10.2337/db08-1618 · Cited by 19
Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells
Katsura, T., Kawamori, D., Aida, E., Matsuoka, T., & Shimomura, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176271 · Cited by 17
Shimamura, M., Karasawa, H., Sakakibara, S., & Shinagawa, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.013 · Cited by 17
Takatani, T., Shirakawa, J., Shibue, K., Gupta, M. K., Kim, H., Lu, S., Hu, J., White, M. F., Kennedy, R. T., & Kulkarni, R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100646 · Cited by 16
Cerf, M. E., Williams, K. G., van Rooyen, J., Esterhuyse, A. J., Muller, C. J. F., & Louw, J. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.07.226 · Cited by 16
Takahashi, R., Ishihara, H., Tamura, A., Yamaguchi, S., Yamada, T., Takei, D., Katagiri, H., Endou, H., & Oka, Y. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00131.2005 · Cited by 16
SGLT2i increased the plasma fasting glucagon level in patients with diabetes: A meta-analysis
Zhu, X., Lin, C., Li, L., Hu, S., Cai, X., & Ji, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174145 · Cited by 16
Diabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 15
Yang, C., Chao, J., & Hsu, W. H. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90201-8 · Cited by 15
Stimulatory Transducing Systems in Pancreatic Islet Cellsa
Emami, S., Régnauld, K., Ferrand, N., Astesano, A., Pessah, M., PHAN, H., Boissard, C., Garel, J., & Rosselin, G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11170.x · Cited by 15
In vivo effects of glucose and insulin on secretion and gene expression of glucagon in rats
Magnan, C., Philippé, J., Kassis, N., Laury, M. C., Pénicaud, L., Gilbert, M., & Ktorza, A. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588284 · Cited by 15
Brief overview: glucagon history and physiology
Robertson, R. P. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0224 · Cited by 13
Nonobese Diabetic (NOD) Mouse Dendritic Cells Stimulate Insulin Secretion by Prediabetic Islets
Durant, S., Alvès, V., Coulaud, J., & Homo‐Delarche, F. (2002) · Autoimmunity · doi:10.1080/08916930 · Cited by 13
A computational systems analysis of factors regulating α cell glucagon secretion
Fridlyand, L. E., & Philipson, L. H. (2012) · Islets · doi:10.4161/isl.22193 · Cited by 12
Lavezzi, J. R., Wesolowski, S. R., O'Meara, M. C., LoTurco, D., Brown, L. D., Hay, W. W., & Rozance, P. J. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00413.2012 · Cited by 11
Shu, S., Dai, A., Wang, J., Wang, B., Feng, Y., Li, J. X., Cai, X., Yang, D., Ma, D., Wang, M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.036 · Cited by 11
Gu, W., Anker, C. C. B., Christiansen, C., Moede, T., Berggren, P., Hermansen, K., Gregersen, S., & Jeppesen, P. B. (2021) · Nutrients · doi:10.3390/nu13072281 · Cited by 12
Lefèbvre, P. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_7 · Cited by 9
The Role of Glucagon in Postprandial Hyperglycemia—The Jury’s Still Out
Bollyky, J., & Greenbaum, C. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1312 · Cited by 9
Self-citationPhysiological and Pathophysiological Control of Glucagon Secretion by Pancreatic α-Cells
Gilon, P., Cheng, R., Lai, B. K., Chae, H., & Gómez-Ruiz, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_37-2 · Cited by 8
Trojan, S. J., Hergenreder, J., Canterbury, L. G., Leonhard, J. T., Clark, W. D., Beckett, J. L., & Long, J. M. (2023) · Translational Animal Science · doi:10.1093/tas/txad078 · Cited by 7
Insulin and Glucagon Secretion in vivo and its Neural Control
Taborsky, G. J. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070206 · Cited by 7
Self-citationde Souza, W. L., Niehues, M. B., Cardoso, A. D. S., de Carvalho, V. V., Perdigão, A., Acedo, T. S., Costa, D. F. A., Tamassia, L. F. M., Kindermann, M., & Reis, R. A. (2024) · Animals · doi:10.3390/ani14233488 · Cited by 6
Kahn, S. E., Edelstein, S. L., Arslanian, S. A., Barengolts, E., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Mather, K. J., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0461 · Cited by 6
Coexistence of glucagon and pancreatic polypeptide in human and rat pancreatic endocrine cells
Park, I.-S., & Bendayan, M. (1992) · Endocrine Pathology · doi:10.1007/bf02921354 · Cited by 5
Fravel, V., Bonn, W. G. V., Gulland, F. M. D., Rios, C. A., Fahlman, A., Graham, J. L., & Havel, P. J. (2016) · Journal of Zoo and Wildlife Medicine · doi:10.1638/2014-0187.1 · Cited by 4
Self-citationGlucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 4
Physiological and Pathophysiological Control of Glucagon Secretion by Pancreatic α-Cells
Gilon, P., Cheng, R., Lai, B. K., Chae, H., & Gómez-Ruiz, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_37 · Cited by 3
Targeting postprandial glycaemia in children with diabetes: O pportunities and challenges
Geyer, M. C., Rayner, C. K., Horowitz, M., & Couper, J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13141 · Cited by 3
Chapter 7 Molecular aspects of the glucagon gene
Laser, B., & Philippé, J. (1997) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(97)80038-5 · Cited by 3
FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN
Eltchaninoff, H., Lacroix, D., & Savoure, D. A. (2013) · Cited by 2
A New Role for Glucagon: From Secondary Hormone to Key Player
De Fano, M., Malara, M., Rucco, S., Manco, M., Fanelli, C. G., Bolli, G. B., & Porcellati, F. (2025) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104233 · Cited by 1
Molecular Mechanism Underlying the Intra-Islet Regulation of Glucagon Secretion
Kawamori, D., & Rohit, N. K. (2011) · InTech eBooks · doi:10.5772/24792 · Cited by 1
Sherin, A., & Paulose, C. S. (2010) · Dyuthi Digital Repository (Cochin University of Science and Technology) · Cited by 1
Glucagon in Islet and Metabolic Regulation
Sandoval, D. A., Tong, J., & Alessio, D. D. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch7 · Cited by 1
THESE POUR LE DOCTORAT EN MEDECINE
Grégoire, B. (2015)
Glucagon in Islet and Metabolic Regulation
Campbell, J. E., & D’Alessio, D. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch8
Fano, M. D., Porcellati, F., Fanelli, C. G., & Bolli, G. B. (2024) · il Diabete · doi:10.30682/ildia2401a
Mini review on antidiabetic botanicals: molecular insights and future prospects
Selvi, G. S. A., Rani, T. P. K. P., Döss, A., Aranganayaki, J., Kabir, N. A., Pole, R. P. P., & Satheesh, S. (2026) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-026-00893-7
Metadata
- Authors
- Greenbaum, C. J., Havel, P. J., Taborsky, G. J., & Klaff, L. J.
- Affiliations
- United States Department of Veterans Affairs (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1991-09-01
- Volume
- 88
- Issue
- 3
- Pages
- 767-773
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295460
- OpenAlex
- W2158603877
- Cited by
- 106
- References
- 46
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 3 · 2021: 8 · 2020: 3 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (2r01dk012829-36, 1f32dk008211-01a1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 12829, DK-08211, DK-17047, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- glucagon suppression, somatostatin, hyperglycemia, pancreatic A cells, glucose infusion, pancreatic islets, glucagon secretion
- MeSH terms
- Insulin Secretion, Alloxan, Animals, Arginine, Dogs, Glucagon, Glucose, Hyperglycemia, Insulin, Islets of Langerhans, Somatostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review